NCT04072276View on ClinicalTrials.gov

Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children

CompletedOBSERVATIONAL
Enrollment

227

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

December 11, 2021

Study Completion Date

December 11, 2021

Conditions
Enterovirus 71 Human
Interventions
BIOLOGICAL

EV71 vaccine

EV71 vaccine with Adjuvant AlPO4 and the placebo (Adjuvant AlPO4 only) were randomly administrated to subject in CT-EV-21 study

Trial Locations (4)

Unknown

Mackay Memorial Hospital, HsincChu, Hsinchu

Mackay Memorial Hospital, Taipei, Taipei

National Taiwan University Hosptial, Taipei

Chang Gung Memorial Hospital, LinKou, Taoyuan District

Sponsors
All Listed Sponsors
lead

Medigen Vaccine Biologics Corp.

INDUSTRY

NCT04072276 - Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children | Biotech Hunter | Biotech Hunter